Saltar al contenido
Merck

Antiangiogenic potential of grape stem extract through inhibition of vascular endothelial growth factor expression.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society (2015-01-03)
D Stagos, A Apostolou, E Poulios, E Kermeliotou, A Mpatzilioti, K Kreatsouli, S D Koulocheri, S A Haroutounian, D Kouretas
RESUMEN

The aim of the present study was to investigate the antiangiogenic potential of a grape stem extract against tube formation by human endothelial cells (EA.hy926). The results showed that at low and non-cytotoxic concentrations (50 and 100 μg/ml) the grape stem extract inhibited tube formation, indicating a possible antiangiogenic activity. Moreover, the results showed that this extract inhibited the expression levels of vascular endothelial growth factor (VEGF), one of the most potent proangiogenic factors, suggesting that the tube formation inhibition by the extract may be exerted through inhibition of VEGF levels. Since it is well established that VEGF prevents apoptosis, the previous finding was further supported by the fact that the grape stem extract induced apoptosis in EA.hy926 cells. Furthermore, it was shown that the extract treatment did not change the levels of the proangiogenic molecules hypoxia inducible factor 1 alpha (HIF-1α) and cyclooxygenase-1 (COX-1). Therefore, these findings indicate that the grape stem extract reduces VEGF levels through mechanisms that may be HIF-1α- and COX-1-independent. The present study is the first showing that grape stem extracts possess antiangiogenic potential. Thus, our findings suggest that since grape stem extracts possess important bioactivities such as antiangiogenic potential, they could be exploited for developing chemopreventive and anticancer agents, while simultaneously protecting the environment through the use of a harmful waste.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Azul de tripano solution, 0.4%, liquid, sterile-filtered, suitable for cell culture
Sigma-Aldrich
Quercetin, ≥95% (HPLC), solid
Sigma-Aldrich
Cobalt(II) chloride, 97%
Sigma-Aldrich
Ácido gálico, 97.5-102.5% (titration)
Sigma-Aldrich
p-Coumaric acid, ≥98.0% (HPLC)
Sigma-Aldrich
Caffeic acid, ≥98.0% (HPLC)
Sigma-Aldrich
Trypan Blue, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Ferulic acid, 99%
Sigma-Aldrich
Kaempferol, ≥97.0% (HPLC)
Sigma-Aldrich
Cobalt(II) chloride, purum p.a., anhydrous, ≥98.0% (KT)
Sigma-Aldrich
(−)-Epicatechin, ≥90% (HPLC)
Sigma-Aldrich
Azul de tripano solution, 0.4%, suitable for microscopy
Supelco
Ácido gálico, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
Quercetin, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Trypan Blue, ≥80% (HPLC), Dye content 60 %
Sigma-Aldrich
Syringic acid, ≥95% (HPLC)
Sigma-Aldrich
(−)-Epicatechin, ≥98% (HPLC), from green tea
Sigma-Aldrich
Kaempferol, ≥90% (HPLC), powder
USP
Quercetin dihydrate, United States Pharmacopeia (USP) Reference Standard
Supelco
(+)-Catechin, analytical standard
Sigma-Aldrich
Ferulic acid, ≥99%
Supelco
Ferulic acid, suitable for matrix substance for MALDI-MS, ≥99.0% (HPLC)
Supelco
Syringic acid, analytical standard
Supelco
Kaempferol, analytical standard
Sigma-Aldrich
Cobalt(II) chloride, AnhydroBeads, −10 mesh, 99.9% trace metals basis
Epicatechin, primary reference standard
Ferulic acid, European Pharmacopoeia (EP) Reference Standard
Supelco
(−)-Epicatechin, analytical standard
Supelco
Caffeic acid, suitable for matrix substance for MALDI-MS, ≥99.0% (HPLC)
Sigma-Aldrich
Cobalt(II) chloride, AnhydroBeads, −10 mesh, 99.995% trace metals basis